Haemonetics (HAE) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…

Haemonetics (HAE) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 22, 2025 (06:25)

Sector: Healthcare

The share price of Haemonetics Corporation (HAE) now

Latest session on the 21st of May for
Haemonetics Corporation is negative
Trading Volume: 305713
Open: 68.35 /  High: 68.575 /  Low: 66.71
Current value: $66.92
What analysts predict: $91.1
52-week High/Low: $94.98 / $55.3
50-Day Moving Average: $63.54 — support level today
200-Day Moving Average: $72.94 — resistance level today

Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Haemonetics stock price in 2025, 2026, 2027. How much will one Haemonetics share be worth in 2025 - 2027?

When should I take profit in Haemonetics stock? When should I record a loss on Haemonetics stock? What are analysts' forecasts for Haemonetics stock? What is the future of Haemonetics stock? We forecast Haemonetics stock performance using neural networks based on historical data on Haemonetics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Haemonetics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Haemonetics shares. This happens once a day.


Historical and forecast chart of Haemonetics stock

The chart below shows the historical price of Haemonetics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Haemonetics stock price can be found in the table below.

Long-term forecasts by years.

Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.

Trending Themes in the Healthcare Sector

Haemonetics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 24 67.86 66.90 68.34 2.15
May 25 68.27 67.20 68.62 2.11
May 26 67.64 67.19 68.51 1.95
May 27 68.15 67.24 68.93 2.51
May 28 69.49 68.56 70.57 2.94
May 29 68.79 68.00 69.56 2.31
May 30 68.51 67.49 68.81 1.95
May 31 68.44 67.71 69.22 2.22
Jun 01 67.75 67.13 68.02 1.33
Jun 02 68.24 67.39 69.09 2.51
Jun 03 68.42 68.10 69.06 1.41
Jun 04 68.47 67.43 68.88 2.15
Jun 05 69.27 68.38 70.19 2.65
Jun 06 69.28 68.34 70.22 2.76
Jun 07 69.00 68.13 69.54 2.07
Jun 08 69.43 69.15 70.24 1.57
Jun 09 70.11 69.24 70.59 1.94
Jun 10 70.17 69.63 70.46 1.19
Jun 11 70.06 69.21 70.62 2.02
Jun 12 69.89 69.55 70.59 1.49
Jun 13 69.40 69.09 70.08 1.43
Jun 14 68.76 68.11 69.49 2.02
Jun 15 70.08 69.35 70.65 1.88
Jun 16 69.46 68.60 70.05 2.11
Jun 17 68.80 67.98 69.15 1.72
Jun 18 68.84 68.27 69.53 1.83
Jun 19 69.02 68.67 69.75 1.57
Jun 20 68.00 67.04 68.38 1.99
Jun 21 68.47 67.43 69.13 2.52
Jun 22 68.06 67.19 68.41 1.82

Haemonetics Daily Price Targets


Haemonetics Stock Forecast 05-24-2025.

Forecast target price for 05-24-2025: $67.86.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.105%.
Pessimistic target level: 66.90
Optimistic target level: 68.34

Haemonetics Stock Forecast 05-25-2025.

Forecast target price for 05-25-2025: $68.27.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.069%.
Pessimistic target level: 67.20
Optimistic target level: 68.62

Haemonetics Stock Forecast 05-26-2025.

Forecast target price for 05-26-2025: $67.64.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 1.915%.
Pessimistic target level: 67.19
Optimistic target level: 68.51

Haemonetics Stock Forecast 05-27-2025.

Forecast target price for 05-27-2025: $68.15.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.452%.
Pessimistic target level: 67.24
Optimistic target level: 68.93

Haemonetics Stock Forecast 05-28-2025.

Forecast target price for 05-28-2025: $69.49.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.855%.
Pessimistic target level: 68.56
Optimistic target level: 70.57

Haemonetics Stock Forecast 05-29-2025.

Forecast target price for 05-29-2025: $68.79.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 2.255%.
Pessimistic target level: 68.00
Optimistic target level: 69.56

HAE (HAE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 70.43 67.68 73.38 7.77
Jul. 72.40 68.78 77.39 11.13
Aug. 74.93 71.34 80.78 11.69
Sep. 70.96 66.77 73.80 9.52
Oct. 71.95 70.23 73.82 4.87
Nov. 72.17 66.40 75.13 11.62
Dec. 71.45 65.88 76.45 13.83

Haemonetics forecast for this year


Haemonetics Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $70.426. Pessimistic: $67.68. Optimistic: $73.38


Haemonetics Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $72.3979. Pessimistic: $68.78. Optimistic: $77.39


Haemonetics Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $74.9319. Pessimistic: $71.34. Optimistic: $80.78


Haemonetics Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $70.9605. Pessimistic: $66.77. Optimistic: $73.80


Haemonetics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $71.9539. Pessimistic: $70.23. Optimistic: $73.82


Haemonetics Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $72.1698. Pessimistic: $66.40. Optimistic: $75.13


Haemonetics Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $71.4481. Pessimistic: $65.88. Optimistic: $76.45



Haemonetics (HAE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 72.31 66.52 75.49 11.88
Feb 68.69 64.16 72.81 11.89
Mar 64.23 62.30 66.47 6.28
Apr 59.99 55.49 64.67 14.19
May 57.53 54.31 58.97 7.90
Jun 61.15 59.07 64.88 8.95
Jul 64.27 60.03 67.68 11.30
Aug 70.12 66.75 73.90 9.68
Sep 73.90 72.21 79.45 9.12
Oct 77.67 73.95 81.40 9.16
Nov 74.33 72.33 80.21 9.82
Dec 81.40 76.27 87.74 13.08

Haemonetics (HAE) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 80.26 78.57 85.95 8.59
Feb 74.16 68.37 75.86 9.87
Mar 70.75 68.91 76.26 9.65
Apr 65.72 61.91 69.34 10.71
May 68.75 66.48 73.08 9.03
Jun 65.45 63.94 69.37 7.83
Jul 69.31 67.37 72.56 7.16
Aug 69.72 66.79 73.56 9.19
Sep 67.98 65.60 69.68 5.85
Oct 69.00 64.51 70.52 8.51
Nov 67.83 66.00 71.29 7.42
Dec 70.81 65.36 75.13 13.01

Haemonetics information and performance

Haemonetics Address

125 SUMMER STREET, BOSTON, MA, US

Market Capitalization: 3 318 800 000 $

Market capitalization of the Haemonetics Corporation is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of HAE shares in the company outstanding by the market price of one share.

EBITDA: 349 564 000 $

EBITDA of Haemonetics is earnings before interest, income tax and depreciation of assets.

PE Ratio: 20.95

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.211

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.31

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 1.925
Quarterly Revenue Growth YOY: -0.037
Trailing PE: 20.95

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.53

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.147

Enterprise Value (EV) /Revenue

EV To EBITDA: 12.69

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 47848900

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Haemonetics Stock)

Should I Buy Haemonetics Shares in 2025 year?

The maximum forecasted share price for next year is $81.40, which is $14.48 higher than the current stock price. By investing in Haemonetics shares today for a one-year period, you could achieve a profit of 21.63%. With an investment horizon of up to two years, the target share price is $80.26. resulting in a profit of 19.93% ($13.34 per share).

Does Haemonetics pay dividends?

No, it does not

Which economic sector do Haemonetics's shares belong to?

Haemonetics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Haemonetics's shares?

You can view all the stocks that are part of the same sector as Haemonetics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.